Nan‐Horng Lin - Concepedia

Author

Nan‐Horng Lin

Abbott Fund

Also Known As

Chung-Yi Wu, N. -Y. Lin, N.-Y. LIN, N.-Y. Lin, N.Y. Lin, Naixin Lin, Nan-Horng Lin, Nan-horng Lin, Nan‐Horng Lin

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United States)Abbott (United Kingdom)Genomics Research Center, Academia Sinica National Taiwan University

About

Nan‐Horng Lin is an author at Abbott Fund specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	1.5K
2	Natural Sciences	15	19	640
3	Social Sciences	5	5	251
4	Engineering	3	3	114
5	Health Sciences	2	2	260

Nan‐Horng Lin

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors Melwyn A. Abreo, Nan‐Horng Lin, David S. Garvey, Journal of Medicinal Chemistry	1996	231
A common glycan structure on immunoglobulin G for enhancement of effector functions Chin‐Wei Lin, Ming‐Hung Tsai, Shiou‐Ting Li, Proceedings of the National Academy of Sciences	2015	203
Identification and Initial Structure−Activity Relationships of (<i>R</i>)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors Mark W. Holladay, James T. Wasicak, Nan‐Horng Lin, Journal of Medicinal Chemistry Pain MedicineNeuropathic PainOrally ActiveMolecular PainPharmacotherapy	1998	131
Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics Zehan Chen, Zhan Xiao, Wen‐Zhen Gu, International Journal of Cancer Selective Chk1 InhibitorsCell DeathCell CycleCancer BiologyTumor Biology	2006	129
Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors Zhi‐Fu Tao, Le Wang, Kent D. Stewart, Journal of Medicinal Chemistry Drug TargetChemical BiologyGrubbs Metathesis MacrocyclizationPharmaceutical ChemistryTumor Biology	2007	88
Discovery of 3<i>H</i>-Benzo[4,5]thieno[3,2-<i>d</i>]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases Zhi‐Fu Tao, Lisa Hasvold, Edward K. Han, Journal of Medicinal Chemistry	2009	84
Synthesis and Evaluation of Nicotine Analogs as Neuronal Nicotinic Acetylcholine Receptor Ligands Nan‐Horng Lin, George M. Carrera, David J. Anderson Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapySystem PharmacologyExperimental PharmacologySocial Sciences	1994	80
ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties James P. Sullivan, Diana L. Donnelly‐Roberts, Clark A. Briggs, Journal of Pharmacology and Experimental Therapeutics	1997	78
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting via Neuronal Nicotinic Acetylcholine Receptors: II. In Vivo Characterization Anthony W. Bannon, Michael Decker, Peter Curzon, Journal of Pharmacology and Experimental Therapeutics	1998	77
Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation Lisa Hasvold, Weibo Wang, Stephen L. Gwaltney, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPyridone-containing Farnesyltransferase InhibitorsMedicineDrug DevelopmentPharmacology	2003	73

Page 1